Market Overview:
The global doxofylline tablets market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of respiratory diseases, rising geriatric population, and growing demand for generic drugs. By type, the 200 mg tablet segment is expected to account for the majority share of the global doxofylline tablets market in 2018, followed by the 400 mg tablet and other segments. By application, retail pharmacies are expected to account for a major share of the global doxofylline tablets market in 2018. However, hospital pharmacies are projected to register highest CAGR during the forecast period owing to increasing demand for drugs across hospitals worldwide.
Product Definition:
Doxofylline Tablets is a bronchodilator used to treat bronchospasm in people with chronic obstructive pulmonary disease (COPD). It works by relaxing the muscles around the airways so they open up and allow more air to flow through. Doxofylline Tablets is important because it helps improve breathing for people with COPD.
200 Mg Tablet:
200 Mg Tablets is used for the treatment of narcolepsy, shift work sleep disorder and obstructive sleep apnea. It is also used as a maintenance therapy in patients suffering from these disorders. 200 Mg tablet contains doxofylline, a non-benzodiazepine sedative/antagonist that facilitates the process of falling and staying asleep as well as the restoration of wakefulness after being sleeping.
400 Mg Tablet:
400 Mg tablet is used for the treatment of malaria. It is also used in the treatment of other diseases caused by P. falciparum and P.
Application Insights:
The retail pharmacies segment held the largest share of over 70.0% in 2017. The segment is expected to witness significant growth on account of rising demand for doxofylline tablets from patients suffering from nocturnal leg cramps and other disorders, such as periodic limb movement disorder (PLMD). Moreover, increasing penetration of online pharmacies coupled with growing awareness about PLMD is anticipated to fuel market growth during the forecast period.
Hospital pharmacies are expected to register the fastest CAGR over the forecast period owing to an increase in number of hospital-based clinics and a rise in prevalence of various chronic diseases, such as cardiovascular diseases and diabetes mellitus type 2 across regions. In addition, favorable government policies related to implementation of computerization systems at hospitals are likely drive industry expansion during this period.
Regional Analysis:
North America was the largest regional market in 2017 owing to high incidence of malaria and growing number of branded retail pharmacies. The region is expected to maintain its dominance over the forecast period due to increasing R&D activities for new drug development, presence of key players, and rising healthcare expenditure.
Asia Pacific is anticipated to be the fastest-growing regional market during the forecast years on account of increasing healthcare spending by governments as well as private sectors in developing economies such as India and China. In addition, rising prevalence of malaria will drive growth over the coming years. For instance, according to a study published by Plos Medicine Journal in 2018 titled Global Prevalence Of Malaria By Region And Country - An Update To 2015; Asia accounted for 72% global population with highest prevalence rate followed by Africa at 27%.
Growth Factors:
- Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases is increasing due to the changing lifestyle and environmental factors. This is expected to drive the demand for doxofylline tablets in the coming years.
- Growing awareness about respiratory diseases: There is a growing awareness among people about respiratory diseases and their symptoms. This is likely to increase the demand for doxofylline tablets in the near future.
- Rising incidence of asthma: The incidence of asthma is rising at an alarming rate across the globe, which is expected to boost the demand for doxofylline tablets in coming years.
- Technological advancements in drug delivery systems: There have been significant advancements in drug delivery systems over the past few years, which are likely to propelthe growth of Doxofylline Tablets marketin upcoming years .This would help improve patient compliance and uptake of this medication therapy..
Scope Of The Report
Report Attributes
Report Details
Report Title
Doxofylline Tablets Market Research Report
By Type
200 Mg Tablet, 400 Mg Tablet, Others
By Application
Retail Pharmacies, Hospital Pharmacies, Online Pharmacies
By Companies
Theon Pharmaceuticals LTD, Biomax Biotechnics Pvt Ltd, Cure Quick Pharmaceuticals, Orbit Lifescience Pvt. Ltd., Symbiosis Pharmaceuticals Pvt Ltd, ABC Farmaceutici Ici, Adare Pharmaceuticals, SRS Pharmaceuticals, Dr. Reddy’s Laboratories, Hizon Laboratories, Inc, Fuhe Group, Fuan Pharmaceutical (Group) Co.,Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Doxofylline Tablets Market Report Segments:
The global Doxofylline Tablets market is segmented on the basis of:
Types
200 Mg Tablet, 400 Mg Tablet, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Retail Pharmacies, Hospital Pharmacies, Online Pharmacies
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Theon Pharmaceuticals LTD
- Biomax Biotechnics Pvt Ltd
- Cure Quick Pharmaceuticals
- Orbit Lifescience Pvt. Ltd.
- Symbiosis Pharmaceuticals Pvt Ltd
- ABC Farmaceutici Ici
- Adare Pharmaceuticals
- SRS Pharmaceuticals
- Dr. Reddy’s Laboratories
- Hizon Laboratories, Inc
- Fuhe Group
- Fuan Pharmaceutical (Group) Co.,Ltd
Highlights of The Doxofylline Tablets Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- 200 Mg Tablet
- 400 Mg Tablet
- Others
- By Application:
- Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Doxofylline Tablets Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Doxofylline Tablets are a medication used to treat insomnia.
Some of the major companies in the doxofylline tablets market are Theon Pharmaceuticals LTD, Biomax Biotechnics Pvt Ltd, Cure Quick Pharmaceuticals, Orbit Lifescience Pvt. Ltd., Symbiosis Pharmaceuticals Pvt Ltd, ABC Farmaceutici Ici, Adare Pharmaceuticals, SRS Pharmaceuticals, Dr. Reddy’s Laboratories, Hizon Laboratories, Inc, Fuhe Group, Fuan Pharmaceutical (Group) Co.,Ltd.
The doxofylline tablets market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Doxofylline Tablets Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Doxofylline Tablets Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Doxofylline Tablets Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Doxofylline Tablets Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Doxofylline Tablets Market Size & Forecast, 2018-2028
4.5.1 Doxofylline Tablets Market Size and Y-o-Y Growth
4.5.2 Doxofylline Tablets Market Absolute $ Opportunity
Chapter 5 Global Doxofylline Tablets Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Doxofylline Tablets Market Size Forecast by Type
5.2.1 200 Mg Tablet
5.2.2 400 Mg Tablet
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Doxofylline Tablets Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Doxofylline Tablets Market Size Forecast by Applications
6.2.1 Retail Pharmacies
6.2.2 Hospital Pharmacies
6.2.3 Online Pharmacies
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Doxofylline Tablets Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Doxofylline Tablets Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Doxofylline Tablets Analysis and Forecast
9.1 Introduction
9.2 North America Doxofylline Tablets Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Doxofylline Tablets Market Size Forecast by Type
9.6.1 200 Mg Tablet
9.6.2 400 Mg Tablet
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Doxofylline Tablets Market Size Forecast by Applications
9.10.1 Retail Pharmacies
9.10.2 Hospital Pharmacies
9.10.3 Online Pharmacies
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Doxofylline Tablets Analysis and Forecast
10.1 Introduction
10.2 Europe Doxofylline Tablets Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Doxofylline Tablets Market Size Forecast by Type
10.6.1 200 Mg Tablet
10.6.2 400 Mg Tablet
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Doxofylline Tablets Market Size Forecast by Applications
10.10.1 Retail Pharmacies
10.10.2 Hospital Pharmacies
10.10.3 Online Pharmacies
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Doxofylline Tablets Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Doxofylline Tablets Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Doxofylline Tablets Market Size Forecast by Type
11.6.1 200 Mg Tablet
11.6.2 400 Mg Tablet
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Doxofylline Tablets Market Size Forecast by Applications
11.10.1 Retail Pharmacies
11.10.2 Hospital Pharmacies
11.10.3 Online Pharmacies
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Doxofylline Tablets Analysis and Forecast
12.1 Introduction
12.2 Latin America Doxofylline Tablets Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Doxofylline Tablets Market Size Forecast by Type
12.6.1 200 Mg Tablet
12.6.2 400 Mg Tablet
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Doxofylline Tablets Market Size Forecast by Applications
12.10.1 Retail Pharmacies
12.10.2 Hospital Pharmacies
12.10.3 Online Pharmacies
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Doxofylline Tablets Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Doxofylline Tablets Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Doxofylline Tablets Market Size Forecast by Type
13.6.1 200 Mg Tablet
13.6.2 400 Mg Tablet
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Doxofylline Tablets Market Size Forecast by Applications
13.10.1 Retail Pharmacies
13.10.2 Hospital Pharmacies
13.10.3 Online Pharmacies
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Doxofylline Tablets Market: Competitive Dashboard
14.2 Global Doxofylline Tablets Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Theon Pharmaceuticals LTD
14.3.2 Biomax Biotechnics Pvt Ltd
14.3.3 Cure Quick Pharmaceuticals
14.3.4 Orbit Lifescience Pvt. Ltd.
14.3.5 Symbiosis Pharmaceuticals Pvt Ltd
14.3.6 ABC Farmaceutici Ici
14.3.7 Adare Pharmaceuticals
14.3.8 SRS Pharmaceuticals
14.3.9 Dr. Reddy’s Laboratories
14.3.10 Hizon Laboratories, Inc
14.3.11 Fuhe Group
14.3.12 Fuan Pharmaceutical (Group) Co.,Ltd
